Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target
Jindong Xie, Anli Yang, Qianwen Liu, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 8
circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer
Yue Zhang, Yeru Tan, Jingping Yuan, et al.
Cancer Letters (2024) Vol. 592, pp. 216907-216907
Closed Access | Times Cited: 7
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer
Yongzhou Luo, W. H. Tian, Da Kang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
Xingxing Li, Yue Wu, Min Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
ALKBH5, an m6A demethylase, attenuates tumor growth and inhibits metastasis in papillary thyroid carcinoma
Yong Zhuang, Qingyan Cai, Xin Hu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
Jianing Zhang, Linwei Li, Manqing Cao, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 11-25
Open Access
ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner
Zi‐Qi Zheng, Feizhi Lin, Baiwei Zhao, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Anticancer Effects of MAPK6 siRNA‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Ceyhun Toruntay, Fatma Şayan Poyraz, Seda Süsgün, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
mTORC1 regulates the proliferation of SOX9+ porcine skin-derived stem cells (pSDSCs) by promoting S6K phosphorylation
Ming-Xin Zang, Geng Zhang, Ying Zhang, et al.
Histochemistry and Cell Biology (2025) Vol. 163, Iss. 1
Closed Access
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Novel Strategy of Antibody Affinity Maturation and Enhancement of Nucleolin‐Mediated Antibody‐Dependent Cellular Cytotoxicity Against Triple‐Negative Breast Cancer
Rita Ribeiro, Jorge M. B. Vítor, Anastasiya Voronovska, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access
Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer
Siyue Zhang, Ning Zhang, Tong Wan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer
W. H. Tian, Lewei Zhu, Yongzhou Luo, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway
Jian Liu, Yong Zhang, Jingjing Wu, et al.
Cancer Genetics (2024) Vol. 284-285, pp. 48-57
Closed Access | Times Cited: 3
mRNA‐Lipid Nanoparticle‐Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple‐Negative Breast Cancer
Wei Li, Masha Huang, Zhaoping Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 3
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model
Karan Mediratta, Sara El‐Sahli, Marie Marotel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
SOD1 inhibition enhances sorafenib efficacy in HBV‐related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS‐mediated cell death
Jooyoung Lee, Ji-Ye Kim, Ryunjin Lee, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 3
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 2
CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer
Yan Zhao, Yangyang Yu, Xiangmin Li, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study
Zhiping Ma, Wei Zhou, Heqing Huang, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1112-1121
Open Access | Times Cited: 2
KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc
Bing Yao, Mengying Xing, Xiangwei Zeng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 2
METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA
Lvyuan Li, Qiling Tang, Junshang Ge, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 2
Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study
Durga Bhavani Kundrapu, Krishna Chaitanya Amajala, Kothapalli Manaswi, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 2
Open Access | Times Cited: 2
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 2
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis
Zi‐Ning Lei, Qiu-Xu Teng, Jagadish Koya, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top